EUVIMEDEUVIMED entdecken
Crossref

Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?

Coyin Oh, Devalingam Mahalingam

AME Clinical Trials Review · 2026-04 · 4 · 14-14

DOI: 10.21037/actr-25-89 ↗

Kurz gefasst

Fachartikel in der Zeitschrift AME Clinical Trials Review, 2026-04. Verfasst von Coyin Oh und 1 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Oh, C., & Mahalingam, D. (2026). Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?. AME Clinical Trials Review, 4, 14-14. https://doi.org/10.21037/actr-25-89

Vancouver

Oh C, Mahalingam D. Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?. AME Clinical Trials Review. 2026;4:14-14. doi:10.21037/actr-25-89

BibTeX
@article{Oh2026,
  author = {Oh, Coyin and Mahalingam, Devalingam},
  title = {Not so fast—should neoadjuvant chemotherapy be routine in resectable pancreatic cancers?},
  journal = {AME Clinical Trials Review},
  year = {2026},
  volume = {4},
  pages = {14--14},
  doi = {10.21037/actr-25-89}
}
Kostenlos starten →